Novo Nordisk and AWS launch AI partnershipNovo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aiming to accelerate drug discovery and modernize Novo Nordisk's operations through agentic AI and cloud technologies. "Partnering with AWS is about making AI a driver of innovation across Novo Nordisk," said Mike Doustdar, president and CEO of Novo Nordisk. Their expertise in rare diseases, proven commercial capabilities and global reach perfectly complement Innate's expertise in CTCL clinical development. Innovent and Daiichi Sankyo strike commercialization dealInnovent Biologics and Daiichi Sankyo entered an exclusive agreement for the commercialization of Vanflyta, or quizartinib, in China. Through collaborative efforts, we aim to bring forward innovative medicines to benefit patients with cancer and further strengthen our leadership in oncology.